SPONSOR
Advenchen Laboratories, LLC
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 1, Phase 2
Conditions studied: Alveolar Soft Part SarcomaLeiomyosarcomaSynovial SarcomaSoft-Tissue SarcomaSolid Tumor
NCT03016819 Phase 3
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Alveolar Soft Part Sarcoma
NCT07392736 Phase 1, Phase 2
Recruiting
A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
Solid Tumor